<DOC>
	<DOCNO>NCT01219582</DOCNO>
	<brief_summary>An observational multicenter study ass effectiveness safety Glucobay®- M daily life treatment type-2 diabetes patients.The study objective investigate effectiveness safety Glucobay® -M blood glucose patient body - weight . Glucobay®- M take 1-3 time daily . All patient type 2 diabetes mellitus , investigator feel addition Glucobay®-M would beneficial patient include non- interventional study . The routine investigation suggest attend physician do diabetic patient . No additional investigation do study purpose . The uncontrolled diabetic patient exist treatment prescribe Glucobay®-M include study take informed consent . The patient ask attend 2 follow visit 6 week . All patient receive least one tablet include safety analysis.The study plan carry 10000 patient 320-350 trial site India .</brief_summary>
	<brief_title>GLucobay M OBservation Study Efficacy Safety Treatment Type-2 Diabetes Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Acarbose</mesh_term>
	<criteria>Female male patient ≥ 18 year age Type 2 Diabetes investigator feel addition Glucobay®M would beneficial patient . The diagnosis make base ADA criterion attend physician . Patients define include study document prescription GlucobayM physician . Patients willing provide sign &amp; date informed consent . Patients willing comply study requirement . According local product information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Diabetes Mellitus Type-2</keyword>
	<keyword>Acarbose</keyword>
	<keyword>Metformin</keyword>
	<keyword>Drug Therapy , Combination</keyword>
</DOC>